Mobile

A Multi-center, Double-Blind, Double-Dummy, Placebo-Controlled, Parallel Panel Study to Assess the Safety, Tolerability, and Glucose-Lowering Efficacy of MK-0893 in Patients With Type 2 Diabetes Melli...

Update Il y a 5 ans
Reference: EUCTR2005-003869-17

A Multi-center, Double-Blind, Double-Dummy, Placebo-Controlled, Parallel Panel Study to Assess the Safety, Tolerability, and Glucose-Lowering Efficacy of MK-0893 in Patients With Type 2 Diabetes Mellitus

Woman and Man

  • | Country :
    • -
  • | organs :
    • -
  • | Specialty :
    • -

Extract

Main objective: (1) To assess the effect of treatment with MK-0893 compared to placebo on 24-hour weighted mean glucose (WMG). (2) To assess the safety and tolerability of MK-0893.

Inclusion criteria

  • Type II Diabetes

Links